INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 44h ago
House PTR4h ago
SEC 13F4h ago
Robinhood Chain4h ago

Most active filers · 30d

  1. 01Kurtz George0B / 239S · 10 late239 trades$59.22M
  2. 02SPSaba Capital Management, L.P.68B / 23S · 14 late91 trades$30.01M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  6. 06SJSheena Jonathan0B / 43S43 trades$3.14M
  7. 07CFCheng Chi Fung0B / 42S42 trades$15.33M
  8. 08RJRubinstein Julie0B / 37S37 trades$6.25M
  9. 09SLSpeiser Michael L0B / 35S35 trades$14.00M
  10. 10RARothblatt Martine A0B / 33S33 trades$5.50M

Form 4 transactions

67,560 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
5
YR
Younessi RaminDirector
CRSCARPENTER TECHNOLOGY CORP
Grant or award
A—
361 sh
Oct 6, 2026Oct 8, 2026
Page 244 of 1689
← PrevNext →
traded Oct 6, 2026
+2d
SEC Form 4

Evidence

3
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$27K
901 sh
Oct 6, 2026Oct 8, 2026
traded Oct 6, 2026
+2dSEC Form 4

Evidence

3
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$15K
499 sh
Oct 6, 2026Oct 8, 2026
traded Oct 6, 2026
+2dSEC Form 4

Evidence

3
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$31K
1,100 sh
Oct 6, 2026Oct 8, 2026
traded Oct 6, 2026
+2dSEC Form 4

Evidence

2
HS
Hata Yujiro SDirector, President and CEO
IDYAIDEAYA Biosciences, Inc.
Option exercise · 10b5-1 plan
M$114K
26.3K sh
Oct 6, 2026Oct 8, 2026
traded Oct 6, 2026
+2dSEC Form 4

Evidence

1
HJ
Hug JoshuaDirector
RELYRemitly Global, Inc.
Open-market sale · 10b5-1 plan
SELL$127K
5,500 sh
Oct 7, 2026Oct 8, 2026
traded Oct 7, 2026
+1dSEC Form 4

Evidence

1
EE
Eberwein Jeffrey E.Director, Chief Executive Officer, 10% Owner
STRRStar Equity Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$9,170
1,000 sh
Oct 8, 2026Oct 8, 2026
traded Oct 8, 2026
+0dSEC Form 4

Evidence

1
HJ
Hug JoshuaDirector
RELYRemitly Global, Inc.
Open-market sale · 10b5-1 plan
SELL$127K
5,500 sh
Oct 6, 2026Oct 8, 2026
traded Oct 6, 2026
+2dSEC Form 4

Evidence

1
EE
Eberwein Jeffrey E.Director, Chief Executive Officer, 10% Owner
STRRStar Equity Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$9,200
1,000 sh
Oct 6, 2026Oct 8, 2026
traded Oct 6, 2026
+2dSEC Form 4

Evidence

1
EE
Eberwein Jeffrey E.Director, Chief Executive Officer, 10% Owner
STRRStar Equity Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$9,170
1,000 sh
Oct 7, 2026Oct 8, 2026
traded Oct 7, 2026
+1dSEC Form 4

Evidence

0
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M$144K
11.9K sh
Oct 7, 2026Oct 8, 2026
traded Oct 7, 2026
+1dSEC Form 4

Evidence

0
HS
Hata Yujiro SDirector, President and CEO
IDYAIDEAYA Biosciences, Inc.
Option exercise · 10b5-1 plan
M—
26.3K sh
Oct 6, 2026Oct 8, 2026
traded Oct 6, 2026
+2dSEC Form 4

Evidence

0
DB
Dageville BenoitDirector
SNOWSnowflake Inc.
Gift · 10b5-1 plan
G—
16.7K sh
Oct 7, 2026Oct 8, 2026
traded Oct 7, 2026
+1dSEC Form 4

Evidence

0
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M$144K
11.9K sh
Oct 8, 2026Oct 8, 2026
traded Oct 8, 2026
+0dSEC Form 4

Evidence

0
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M$144K
11.9K sh
Oct 6, 2026Oct 8, 2026
traded Oct 6, 2026
+2dSEC Form 4

Evidence

0
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M—
11.9K sh
Oct 7, 2026Oct 8, 2026
traded Oct 7, 2026
+1dSEC Form 4

Evidence

0
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M—
11.9K sh
Oct 8, 2026Oct 8, 2026
traded Oct 8, 2026
+0dSEC Form 4

Evidence

0
RS
Regnery David SDirector, Chair and CEO
TTTrane Technologies plc
Option exercise · 10b5-1 plan
M—
48.1K sh
Oct 6, 2026Oct 8, 2026
traded Oct 6, 2026
+2dSEC Form 4

Evidence

0
HA
Haro AlexDirector
LIFLife360, Inc.
Option exercise · 10b5-1 plan
M$126K
50.0K sh
Oct 6, 2026Oct 8, 2026
traded Oct 6, 2026
+2dSEC Form 4

Evidence

0
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M—
11.9K sh
Oct 6, 2026Oct 8, 2026
traded Oct 6, 2026
+2dSEC Form 4

Evidence

63
BP
Barcos Melgar PabloVP INVESTMENT OFFICER
VTMXVesta Real Estate Corporation, S.A.B. de C.V.
Open-market sale
SELL$22K
6,154 sh
Aug 25, 2026Oct 7, 2026
traded Aug 25, 2026
+43dSEC Form 4

Evidence

49
KJ
Knotnerus Tim JasperDirector, Chief Executive Officer
AGMBAgomAb Therapeutics NV
Open-market purchase
BUY$51K
6,000 sh
Oct 5, 2026Oct 7, 2026
traded Oct 5, 2026
+2dSEC Form 4

Evidence

46
KV
Kemula Pierre Thadee VictorChief Financial Officer
AGMBAgomAb Therapeutics NV
Open-market purchase
BUY$43K
5,000 sh
Oct 6, 2026Oct 7, 2026
traded Oct 6, 2026
+1dSEC Form 4

Evidence

46
KV
Kemula Pierre Thadee VictorChief Financial Officer
AGMBAgomAb Therapeutics NV
Open-market purchase
BUY$26K
3,000 sh
Oct 6, 2026Oct 7, 2026
traded Oct 6, 2026
+1dSEC Form 4

Evidence

42
KV
Kemula Pierre Thadee VictorChief Financial Officer
AGMBAgomAb Therapeutics NV
Open-market purchase
BUY$17K
2,000 sh
Oct 6, 2026Oct 7, 2026
traded Oct 6, 2026
+1dSEC Form 4

Evidence

40
FA
Freidin AaronChief Financial Officer
GRALGRAIL, Inc.
Open-market sale
SELL$3.46M
23.6K sh
Oct 5, 2026Oct 7, 2026
traded Oct 5, 2026
+2dSEC Form 4

Evidence

40
NW
Nilan Nicholas WilliamGeneral Manager-US
ARQQArqit Quantum Inc.
Open-market sale
SELL$12K
522 sh
Oct 5, 2026Oct 7, 2026
traded Oct 5, 2026
+2dSEC Form 4

Evidence

40
PJ
Partridge Andrew JohnChief Growth Officer
GRALGRAIL, Inc.
Open-market sale
SELL$1.15M
7,873 sh
Oct 5, 2026Oct 7, 2026
traded Oct 5, 2026
+2dSEC Form 4

Evidence

40
BI
Brockman IvanDirector
VRAVera Bradley, Inc.
Open-market purchase
BUY$50K
10.0K sh
Oct 6, 2026Oct 7, 2026
traded Oct 6, 2026
+1dSEC Form 4

Evidence

38
TO
Troim Tor OlavDirector
BORRBorr Drilling Ltd
Open-market purchase
BUY$6.36M
1.50M sh
Oct 6, 2026Oct 7, 2026
traded Oct 6, 2026
+1dSEC Form 4

Evidence

38
PE
Partners Group Private Equity II, LLCAffiliate of the Adviser
NANAPartners Group Private Equity Fund, LLC
Open-market sale
SELL$29.96M
13.62M sh
Oct 1, 2026Oct 7, 2026
traded Oct 1, 2026
+6dSEC Form 4

Evidence

38
KJ
Knotnerus Tim JasperDirector, Chief Executive Officer
AGMBAgomAb Therapeutics NV
Open-market purchase
BUY$44K
5,000 sh
Oct 6, 2026Oct 7, 2026
traded Oct 6, 2026
+1dSEC Form 4

Evidence

37
Tenev VladimirDirector, Chief Executive Officer
HOODRobinhood Markets, Inc.
Open-market sale · 10b5-1 plan
SELL$22.10M
193.9K sh
Oct 5, 2026Oct 7, 2026
traded Oct 5, 2026
+2dSEC Form 4

Evidence

35
LA
Leaver AndrewChief Executive Officer
ARQQArqit Quantum Inc.
Open-market sale
SELL$60K
2,535 sh
Oct 5, 2026Oct 7, 2026
traded Oct 5, 2026
+2dSEC Form 4

Evidence

34
Tenev VladimirDirector, Chief Executive Officer
HOODRobinhood Markets, Inc.
Open-market sale · 10b5-1 plan
SELL$2.55M
22.2K sh
Oct 5, 2026Oct 7, 2026
traded Oct 5, 2026
+2dSEC Form 4

Evidence

33
Tenev VladimirDirector, Chief Executive Officer
HOODRobinhood Markets, Inc.
Open-market sale · 10b5-1 plan
SELL$17.99M
158.9K sh
Oct 5, 2026Oct 7, 2026
traded Oct 5, 2026
+2dSEC Form 4

Evidence

33
GO
Gur OsnatDirector
BOSCBOS BETTER ONLINE SOLUTIONS LTD
Open-market sale
SELL$35K
7,500 sh
Oct 5, 2026Oct 7, 2026
traded Oct 5, 2026
+2dSEC Form 4

Evidence

32
RG
Ritchie GarthDirector
ARQQArqit Quantum Inc.
Open-market sale
SELL$3,021
127 sh
Oct 5, 2026Oct 7, 2026
traded Oct 5, 2026
+2dSEC Form 4

Evidence

32
FP
Feenan PaulChief Revenue Officer
ARQQArqit Quantum Inc.
Open-market sale
SELL$13K
533 sh
Oct 5, 2026Oct 7, 2026
traded Oct 5, 2026
+2dSEC Form 4

Evidence

32
WP
Willcocks PatrickGeneral Counsel
ARQQArqit Quantum Inc.
Open-market sale
SELL$14K
588 sh
Oct 5, 2026Oct 7, 2026
traded Oct 5, 2026
+2dSEC Form 4

Evidence

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
  4. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  5. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  6. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  7. SELLADUSAddus HomeCare CorpNov 6 – Nov 96 insiders$16.28M
  8. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K